It seems like 12 short months ago we were told to expect label expansion in as little as 3 months. When has Clinuvel ever surprised on the upside?
No big deal to the bottom line however with the EU rollout so disappointing, 10% of not much is even less. Lets get 12-18 year olds treated in the US. Whats happening there?
Ann: SCENESSE in Adolescent EPP Study, page-3
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.00 |
Change
-0.160(1.13%) |
Mkt cap ! $707.5M | |||
| Open | High | Low | Value | Volume |
| $14.20 | $14.24 | $13.97 | $382.0K | 26.99K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 122 | $13.97 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.00 | 201 | 12 |
View Market Depth
| Last trade - 13.09pm 15/08/2024 (20 minute delay) ? |
| CUV (ASX) Chart |